Page last updated: 2024-12-05

6-hydroxyhexanoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID14490
CHEMBL ID2006530
CHEBI ID17869
SCHEMBL ID28484
MeSH IDM0118411

Synonyms (40)

Synonym
nsc617319
nsc-617319
5-hydroxypentanecarboxylic acid
6-hydroxy caproic acid
6-hydroxycaproic acid
5-carboxypentanol
epsilon-hydroxyhexanoic acid
epsilon-hydroxycaproic acid
CHEBI:17869 ,
NCI60_005214
hexanoic acid, 6-hydroxy-
C06103
1191-25-9
6-hydroxyhexanoic acid ,
6-hydroxy-hexanoic acid
LMFA01050015
unii-3y3ox37nm8
3y3ox37nm8 ,
AKOS006223967
GEO-02681
FT-0633442
S10488
6-hydrocaproic acid
.epsilon.-hydroxycaproic acid
SCHEMBL28484
6-hydroxy-caproic acid
CHEMBL2006530
6-hydroxyhexanoic acid #
W-200089
DTXSID00152316
mfcd00046560
hexanoic acid,6-hydroxy-
DS-13995
Q27102678
AM10824
6-hydroxyhexanoic acid, 95%, may cont. variable amounts of dimer
SY032043
A892649
EN300-137305
CS-0158392
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
bacterial xenobiotic metaboliteAny bacterial metabolite produced by metabolism of a xenobiotic compound in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
6-hydroxy monocarboxylic acid
straight-chain fatty acidAny fatty acid whose skeletal carbon atoms form an unbranched open chain.
omega-hydroxy-medium-chain fatty acidA omega-hydroxy-fatty acid with a chain length ranging from C6 to C12.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (38.46)18.7374
1990's0 (0.00)18.2507
2000's3 (23.08)29.6817
2010's4 (30.77)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.65 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index56.96 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]